MSRM — Mushrooms Share Price
Last trade - 00:00- $0.51m
- $0.49m
- $0.05m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.1 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.06% | ||
| Return on Equity | -26.05% | ||
| Operating Margin | -275.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011E | 2012E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.05 | 0.04 | 0.13 | 0.03 | 0.05 | n/a | n/a | -20.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mushrooms, Inc. is a pioneering biotech company. It is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The Company is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. It is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. It also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.
Directors
- Phillip Malkemes PRE
- Patrick Montalban CEO (55)
- Danny Mitchell VPR (82)
- Bruce Hirsche DRC (73)
- Arman Tabatabaei IND
- Last Annual
- December 31st, 2010
- Last Interim
- March 31st, 2011
- Incorporated
- April 16th, 2002
- Public Since
- November 17th, 2006
- No. of Employees
- 34
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 39,435,760
- Address
- 23150 Fashion Drive, Suite 231, ESTERO, 33928
- Web
- https://www.mushroomsinc.com/
- Phone
- +1 4068735580
- Auditors
- Richey, May & Co., P.C.
Upcoming Events for MSRM
Similar to MSRM
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Beter Bed Holding BV
Pink Sheets on Nasdaq
Better for You Wellness
Pink Sheets on Nasdaq
FAQ
As of Today at 22:10 UTC, shares in Mushrooms are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Mushrooms last closed at $0.01 and the price had moved by -53.76% over the past 365 days. In terms of relative price strength the Mushrooms share price has underperformed the S&P500 Index by -56.8% over the past year.
There is no consensus recommendation for this security.
Find out moreMushrooms does not currently pay a dividend.
Mushrooms does not currently pay a dividend.
Mushrooms does not currently pay a dividend.
To buy shares in Mushrooms you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Mushrooms had a market capitalisation of $0.51m.
Here are the trading details for Mushrooms:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MSRM
Based on an overall assessment of its quality, value and momentum Mushrooms is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mushrooms. Over the past six months, its share price has outperformed the S&P500 Index by +12.21%.
As of the last closing price of $0.01, shares in Mushrooms were trading -15.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mushrooms PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mushrooms' management team is headed by:
- Phillip Malkemes - PRE
- Patrick Montalban - CEO
- Danny Mitchell - VPR
- Bruce Hirsche - DRC
- Arman Tabatabaei - IND